cefoxitina richet 1 g polvo para solución inyectable i.v.
laboratorios richet s.a. - cefoxitina (cefoxitina sÓdica) - cefoxitina (cefoxitina sÓdica)....1.0 g
cefoxitina (sodica) 1 g polvo para solucion inyectable i.m., i.v.
north china pharmaceutical co. ltd - cefoxitina sÓdica - cefoxitina sÓdica....1.0 g
mefoxin pws 2gm/vial powder for solution
merck frosst canada & cie, merck frosst canada & co. - cefoxitin (cefoxitin sodium) - powder for solution - 2g - cefoxitin (cefoxitin sodium) 2g - cephamycins
mefoxin pws 1gm/vial powder for solution
merck frosst canada & cie, merck frosst canada & co. - cefoxitin (cefoxitin sodium) - powder for solution - 1g - cefoxitin (cefoxitin sodium) 1g - cephamycins
mefoxin inj 1gm/vial add-vantag powder for solution
merck frosst canada & cie, merck frosst canada & co. - cefoxitin (cefoxitin sodium) - powder for solution - 1g - cefoxitin (cefoxitin sodium) 1g - cephamycins
mefoxin inj 2gm/vial add-vantag powder for solution
merck frosst canada & cie, merck frosst canada & co. - cefoxitin (cefoxitin sodium) - powder for solution - 2g - cefoxitin (cefoxitin sodium) 2g - cephamycins
mefoxin pws inj 10gm/vial powder for solution
merck frosst canada & cie, merck frosst canada & co. - cefoxitin (cefoxitin sodium) - powder for solution - 10g - cefoxitin (cefoxitin sodium) 10g - cephamycins
warfarin sodium tablet
bryant ranch prepack - warfarin sodium (unii: 6153cwm0cl) (warfarin - unii:5q7zvv76ei) - warfarin sodium 2 mg
warfarin sodium tablet
pd-rx pharmaceuticals, inc. - warfarin sodium (unii: 6153cwm0cl) (warfarin - unii:5q7zvv76ei) - warfarin sodium 4 mg
piperacillin and tazobactam- piperacillin sodium and tazobactam sodium injection, powder, for solution
sandoz inc - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx), tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w) - piperacillin anhydrous 3 g in 15 ml - piperacillin and tazobactam for injection is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in fewer than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of staphylococcus aureus . postpartum endometritis or pelvic inflammat